Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

5.62
Delayed Data
As of 3:59pm ET
 -0.23 / -3.93%
Today’s Change
3.71
Today|||52-Week Range
10.15
+23.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization2.0K1.0K2.0K1.0K
 
 
 
 
 
 
Operating ExpensesGross Income-2.0K-1.0K-2.0K-1.0K
 
 
 
 
 
General Expenses1.7M1.9M1.7M1.7M
 
 
 
 
 
Research And Development858.0K1.3M1.1M946.0K
 
 
 
 
 
Total Operating Expenses1.7M1.9M1.7M1.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.7M-1.9M-1.7M-1.7M
 
 
 
 
 
Other Expenses93.0K-5.0K0.0031.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M-1.9M-1.6M-1.6M
 
 
 
 
 
Income Taxes-4.0K0.000.000.00
 
 
Net Income-1.6M-1.9M-1.6M-1.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.1M10.1M10.8M10.8M
 
 
 
 
 
Shares To Calculate EPS Diluted10.1M10.1M10.8M10.8M
 
 
 
 
 
 
Earnings Per ShareEPS---$0.19-$0.15-$0.15
 
 
 
 
EPS Diluted-$0.16-$0.19-$0.15-$0.15